Posts Tagged ‘psychosis’

52% of foster kids are prescribed psych drugs—One of them is fighting back

Thursday, June 23rd, 2011

By CCHR Int
June 23, 2011

At just 6 years of age, still grieving over the death of the only mother he’d ever known, his foster mother, Giovan Bazan received the first of many psychiatric “diagnoses” and drugs that would plague him for the next twelve years of his life. Moved from foster home to  foster home, orphanages and other modes of state care, Giovan was stigmatized with a plethora of psychiatric diagnoses and drugs until the age of 18, when he could finally make his own medical decisions and quit. Now a child advocate working part time at the Division of Family and Children Services (DFCS) in Georgia, Giovan is on a mission: To get a full-time job with DFCS and help enact laws to combat the wholesale labeling and drugging of foster children. In the video below, Giovan tells his story and why he decided to fight back against the abuse of kids in foster care.

(Story continues below)

Foster kids—often removed from family homes because of abuse—are further abused when they are prescribed psychotropic drugs under state care. Many of these children are on cocktails of prescribed drugs, including antipsychotics and antidepressants with documented side effects of diabetes, stroke, mania, psychosis, tumors, coma, suicide and death.

Yet, the rates with which these children are being given drugs has been increasing. The antipsychotic use rate among foster kids increased by 5.6% between 2004 and 2007 (from 11.7 percent to 12.4 percent). Another study in Pediatrics, revealed that youth in foster care covered by Medicaid insurance receive psychotropic medication at a rate more than 3 times that of Medicaid-insured youth who qualify by low family income.

Only half of state child welfare systems have a policy to review usage of these drugs, and those are weak policies at that.

The psychiatric drugging of foster kids has caused so much concern nationally that in July 2010, the Government Accountability Office (GAO) started an investigation into the use of these drugs in foster care, as they are widely used in dangerous combinations, and for so-called “off-label” uses to treat symptoms for which they have not been medically approved. The GAO is looking into the estimated hundreds of millions of dollars of fraud arising from this and is collecting and analyzing data from Florida, Maryland, Massachusetts, Minnesota, Oregon and Texas.

For more information on the psychiatric drugging of children, watch these videos:

Psychiatry—Labeling Kids with Bogus ‘Mental Disorders’


Drugging Our Children—Side Effects

« Return to news items


Share

US expert slams Patrick McGorry’s psychosis model

Monday, June 13th, 2011

Note from CCHR:   CCHR International was the first organization  to expose  the complete insanity of psychiatrist and “Australian of the Year” Patrick McGorry’s campaign to “pre-diagnose” children before they ‘develop” mental disorders.  But we’re no longer the only ones.   Even his fellow psychiatrists are attacking it.  Let’s just break it down; psychiatrists admit there are no medical tests in existence to prove any child suffers from a mental ‘illness.”  Diagnoses is based solely on opinion, yet more than 20 million children worldwide have been ‘diagnosed’ and prescribed dangerous and potentially lethal drugs based on nothing more than psychiatry’s junk science.     Yet this doesn’t seem to be a problem to McGorry, or Australia for that matter, considering they just allocated $400 million to McGorry’s  crystal ball theory of “pre-diagnoses,”  for ‘psychosis’ adding even  more lunacy to the child labeling and drugging epidemic that is literally killing kids.   Now that, is psychotic – and it’s psychiatrist Patrick McGorry that’s leading the way.

The Australian – June 14, 2011

by Sue Dunlevy

PATRICK McGorry’s model of early diagnosis of psychosis, favoured by the federal government and the Coalition in their mental-health policies, has come under attack from a leading US psychiatrist, who warns that predicting psychosis is unreliable and could lead to patients being wrongly medicated.

Allen Frances, who chaired the committee that produced the current diagnostic bible for psychiatry, the DSM-IV, has warned that Professor McGorry’s Early Psychosis Intervention Centres do not have a reliable early diagnosis tool.

Professor Frances, an emeritus professor at Duke University in North Carolina, fears early diagnosis could lead to people without psychosis being put on medications that have serious side-effects, including massive weight gain.

He has also attacked the Gillard government’s plans to spend $222 million expanding Professor McGorry’s EPIC program by another 16 centres as a “vast untried public-health experiment”.

“The Australian experiment will be flying blind on an airplane that is not at all ready to leave the ground,” he said in a blog posted on Psychology Today in the US.

His concerns are shared by Adelaide University psychiatry professor Jon Juredini, who says the Gillard government should have shared mental-health funding around many different early intervention projects to see what worked best. “A lot of the evaluation of EPIC shows any advantages it has disappear over time, so that tends to suggest that in terms of intervention they are good while they are happening, but they don’t necessarily give long-term protection,” Professor Juredini told The Australian.

Their criticism came as the past president of the Royal Australian College of Psychiatrists, Louise Newman, attacked the $197 million the government will spend on expanding the number of Headspace youth mental health centres from 60 to 90.

“There have been certain statements about the efficacy of  the Headspace approach that have been overstated,” she told Australian Doctor magazine.

Early intervention to prevent mental illness needed to happen at a much earlier stage of development than adolescence, Dr Newman said.

A spokeswoman for Mental Health Minister Mark Butler said the government was making substantial investments in youth mental health and early psychosis prevention services. “We are confident these evidence-based models will be of benefit to young Australians,” she said.

Professor Frances’s arguments have been seized on by Scientologists, who argue against the notion of mental illness.

Although Professor Frances chaired the committee that produced the fourth version of the Diagnostic and Statistical Manual of Mental Disorders in 1994, he has been left off the panel developing the fifth version.

He has written extensively of his concerns about how strict medical definitions of mental illness can lead to misdiagnosis by non-experts.

Professor McGorry dismissed Professor Frances’s attack as a “beat-up”, and said no one received anti-psychotic drugs at his centres unless they had had a psychotic episode.

While Professor Frances agreed that Professor McGorry did not recommend anti-psychotic medication as a preventive measure, he feared general practitioners might overuse the drugs if they started using Professor McGorry’s diagnostic tool for early psychosis.

Professor Frances said in his Psychology Today blog that early intervention to prevent psychosis required first that there be an accurate tool to identify who would become psychotic.

“The false positive rate in selecting pre-psychosis is at least 60-70 per cent in the very best hands and may be as high as 90 per cent in general practice . . . these are totally unacceptable odds,” he said.

Professor McGorry agreed that false positive rates of diagnosing prepsychosis were high, but said the first line of treatment for people who had sub-threshold psychosis was supportive care.

http://www.theaustralian.com.au/national-affairs/us-expert-slams-patrick-mcgorrys-psychosis-model/story-fn59niix-1226074544901

« Return to news items


Share

The Death of Mental Illness

Wednesday, May 18th, 2011

PsychCentral
By Will Meecham, MD, MA
May 18, 2011

In writing this post, I may be crashing the American Psychological Association’s annual blog party. Naturally, I’m in favor of joining others to increase awareness and reduce stigma around psychiatric problems. But despite the spirit of solidarity, I’m perhaps an outsider, because I no longer believe ‘mental illness’ serves as a helpful concept.

In this era of burgeoning diagnoses, it’s a bit awkward to declare our great emperor, the Diagnostic and Statistical Manual of Mental Disorders (DSM), naked and unfleshed. Especially at a party.

Let me be clear: people sometimes behave in ways that look incomprehensible or even insane. Suicidal behavior, profoundly delusional speech, and irresistible compulsions represent severe behavioral problems for individuals and society. No doubt they stem from cognitive activity and emotional tones that differ from average day-to-day awareness. These sorts of disordered conduct do indeed derive from ‘mental’ processes, but do they qualify as ‘illnesses?’

It seems to me that to define something as a disease implies that we can also recognize its absence. But this isn’t always easy with mental conditions. Take the example of suicide. Frank attempts on one’s own life lie at the extreme end of a spectrum of self-destructive thoughts and actions. Some of these get labeled as mental illness, and some don’t, but the distinction is rather arbitrary.

I suspect a majority of the population would have to admit to moments of wondering if life is worth the effort, and to brief thoughts of ending it. We aren’t mentally ill just because we have moments of doubt. How frequently or how seriously does a person have to question life’s value in order to be deemed sick? Or consider that a man with advanced emphysema who continues to smoke kills himself just as surely as a woman who takes an overdose of pills. But our culture doesn’t define the dying smoker’s senseless behavior as mental illness. What’s the difference? Does the fact that a man doesn’t admit to wanting to end his life relieve him of responsibility for doing so? The honestly suicidal woman is arguably more rational and clear than the smoker clouded in denial who works toward the same end.

Or consider delusions. If a man believes the CIA has implanted thought control devices in his brain, everyone agrees he is out of touch with reality; we call this paranoid schizophrenia. But if a political leader proclaims that environmental exploitation isn’t a problem, even as the ecosystem destabilizes, no one considers her delusion a sign of mental illness. Director Tom Shadyac’s delightful documentary, I Am, makes a similar point about how many of the values our culture promotes are actually insane.

What about obsessions? Someone who won’t leave the house without checking the doors and windows two dozen times earns a diagnosis of OCD. But a billionaire obsessed with accumulating ever more money gets worshiped like a modern deity.

Furthermore, psychiatrists dismiss highly positive spiritual experiences as delusional and hallucinatory simply because such states hint at phenomena that aren’t endorsed by materialist science. When for a time I entered what seemed like profoundly awakened consciousness back in 2000, I wasn’t congratulated. The psychiatrists labelled my experience a ‘manic psychosis’ and started me on Haldol. I was too trusting to doubt them at the time, but now I wish they’d referred me to a spiritual leader rather than the psychiatric ward.

Obviously, people spiral into all kinds of behavioral crises and need help. Sometimes they recognize their need for assistance, and sometimes not. But whether a particular maladaptive conduct gets labelled as mental illness or not has to do with cultural values, not medical science. If there weren’t so much stigma, and so much risk of over-medication, it wouldn’t matter. But a life may be derailed for years (or forever) after the hammer of a major psychiatric diagnosis shatters a person’s reputation and self-image.

Tradition tells us that the seventh century Korean Zen Buddhist Wonhyo achieved enlightenment when following an exhausting journey without water he collapsed at night in a deep cavern. He found an ivory bowl while groping in the dark, and relished the sweet water it contained with a rush of relief. But when he arose the next morning he realized he had reclined in a tomb. The ‘bowl’ was the cap of a human skull, and he saw that he had not drunk clean water but a putrified soup of decay. At first nauseated and repulsed, he spiritually ‘awoke’ shortly afterward when he recognized how what he thought about reality (and not reality itself) so decisively determined his experience.

The conditions we label mental illness are a bit like that, only in reverse. In my case a lifetime of profound sadness, plus the ministrations of countless therapists and doctors, convinced me that I suffered from a major psychological disease caused by my upbringing (which included early bereavement and severe child abuse) and genetic endowment (my depressed mother committed suicide). This view of myself had a major impact on my self esteem for much of my life, but I don’t believe it anymore. Now I understand that my sadness was a natural grieving reaction that may have been prolonged because no one validated my understandable sorrow after such a childhood.

No longer do I see my melancholy as the psychiatric equivalent of a decomposing skullcap. I now appreciate that life dealt me hardship early on, and I reacted normally. With time I overcame my grief, so that the traumatic past now stands as one of my most important teachers. Despite its ordeals, it led me to how I feel today: contented and more than a little knowledgeable about misfortune and its transcendence. The skullcap has transformed into the ivory bowl. Of course, neither perspective is necessarily ‘correct’ in any objective sense. But which picture I hold in mind has a powerful impact on how I feel.

I’ve already sketched how psychiatrists diagnosed as mania an experience that in another time and place would have been viewed as a divinely granted spiritual awakening. My epiphany landed battered and defamed in the charnel grounds of mental illness, when it could have been an elegant container of grace.

How experiences are framed determines how we feel about ourselves and how others view us. Does the frame of mental illness serve the majority of patients? Or does it more often sap vitality and confidence? I read in many blogs of the relief people feel when doctors finally define their problems as diagnosable mental diseases. I remember reacting similarly myself when a lifetime of moodiness finally earned me the ‘bipolar’ label. It felt so comforting to have my condition named and seemingly validated. But instead of decisively helpful treatments, the mental health system strung me along with decades of therapy and thousands of little pills, none of which improved my mood or outlook very much. It seems to me that if psychiatric diagnoses were truly valuable, they would guide clinicians to life-changing therapeutic choices. But how often do people diagnosed with ‘major mental illness’ leave the Psychiatry Department with an effective cure? Although they may feel transiently relieved, they and their family now must endure the burden of ‘knowing’ their minds are sick.

Read entire article here:  http://blogs.psychcentral.com/happiness/2011/05/the-death-of-mental-illness/

« Return to news items


Share

Autopsy of Florida School Board Shooter Shows Antidepressant in His System

Thursday, April 14th, 2011

The Walton Sun – April 14, 2011
By S. Bradly Calhoun

10 recent massacres were committed by those under the influence of psychiatric drugs resulting in 54 dead and 105 wounded

PANAMA CITY — The man who held the Bay District School Board hostage before killing himself last year had an antidepressant, acetaminophen and foot fungus medication in his system, his autopsy revealed. The report on Clay Duke was released Wednesday by the Bay County medical examiner’s office.

Duke, 56, killed himself Dec. 14 after firing several shots at school board members during a public meeting. Duke was brought down by three bullets from Mike Jones, the district’s chief of safety.

A toxicology report revealed that at the time of Duke’s death, he had atropine, a drug commonly used in emergency rooms to resuscitate dying patients; acetaminophen; Terbinafine, used to fight fungal infections in fingers and toes; and Citalopram, an antidepressant found in Celexa, in his system.

Forest Laboratories Inc., which makes Celexa, notes on its website the company urges patients to “call a health care provider right away if you or your family member has any of the following symptoms, especially if they are new, worse, or worry you: thoughts about suicide or dying, attempts to commit suicide, new or worse depression, new or worse anxiety, feeling very agitated or restless, panic attacks, trouble sleeping (insomnia), new or worse irritability, acting aggressive, being angry, or violent, acting on dangerous impulses, an extreme increase in activity and talking (mania), other unusual changes in behavior or mood.”

Attempts to contact officials with Forest Laboratories were unsuccessful Wednesday.

To read international studies and drug regulatory warnings on psychiatric drugs click here and use the red search box with the following terms; violence;mania; homicidal; psychosis; http://www.cchrint.org/psychdrugdangers/drug_warnings.php

To see what doctors, pharmacists, health care providers and others have reported on the antidepressant Celexa click here and simply chose Celexa from the drop down menu Drug Name/Drug Class http://www.cchrint.org/psychdrugdangers/medwatch_psych_drug_adverse_reactions.php

« Return to news items


Share

Panel to Examine Murder and Suicide Associated With Antidepressants

Tuesday, March 22nd, 2011

The Huffington Post, March 22, 2011
by Dr. Peter Breggin

Click image to visit the Psychiatric Drug Database

On Saturday morning April 9th of this year, a panel discussion will be held for the public and professionals on the theme of “Psychiatric Drug Tragedies: Personal, Legal and Medical Perspectives.”

The two-hour presentation focuses on suicide and murder potentially caused by antidepressant medications. It is part of the international Empathic Therapy Conference put on by the Center for the Study of Empathic Therapy, Education & Living (April 8-10, 2011 in Syracuse, New York).

The panel will present a unique examination of an antidepressant-related suicide from three perspectives: Mathy Downing, the mother of a twelve-old-child who committed suicide; Karl Protil, the lawyer in her case, which was settled without any admission of negligence; and myself as the medical expert in the case. Mathy will be accompanied by her surviving daughter. Other family members will tell the stories of two more children who committed suicide, a father who committed suicide, and a husband who murdered his two young children–all while taking prescribed antidepressants.

A great deal is now known about suicide and violence in association with the newer antidepressants such as Prozac (fluoxetine), Paxil (paroxetine), Zoloft (sertraline), Luvox (fluvoxamine), Celexa (escitalopram), Lexapro (escitalopram), Cymbalta (duloxetine), Effexor (venlavaxine), Pristiq desvenlafaxine), and Wellbutrin (bupropion).

The FDA has imposed a Black Box on all antidepressant labels that warns against the risk of suicidal behavior in children, youth and young adults. Click here to find the example of Prozac’s official prescribing information. More importantly and more broadly, the new labels also warn about the risk of aggression, hostility, mania, and an overall worsening of the individual’s mental condition, for all ages. The new FDA-approved labels also include a Medication Guide, which the FDA urges prescribers to give to patients and their families. Originally intended for children taking antidepressants, it now has no age limitation and pertains to all ages. The Medication Guide warns patients and their families to be aware of the possibility of suicidal and violent behavior, mania, and a long litany of other dangerous mental abnormalities.

The new FDA-approved antidepressant labels confirm that the risks are highest at the start of medication therapy or during changes in dose, either up or down. To a great extent, the labels read like my prior publications, one of which was given by the FDA to its outside expert committee that recommended the changes to the labels.

Unfortunately, many psychiatrists, internists, family doctors, nurse practitioners and other professionals continue to prescribe these medications, too often without providing adequate information to the patient and the family. As a result, I was asked to write about the implications of these new labels for the most widely read psychiatric journal for primary care prescribers. The panel at the Empathic Therapy Conference, the first of its kind, will explore these tragedies and put a human face on them through the presence and presentations of surviving family members.

Other aspects of the conference will describe empathic approaches to helping a wide variety of emotional conditions and problems in children and adults. Speakers will bring unique and inspiring approaches to children and adults given psychiatric diagnoses, ordinary folks who are suffering from stress, street people overcome by psychosis, military personnel recovering from PTSD and head injuries, and elderly victims of dementia. Professionals and the general public are welcome at the Empathic Therapy Conference in Syracuse, New York, April 8-10, 2011. Continuing education credits (CEs) for 29.5 hours are available.

Peter R. Breggin, MD is a psychiatrist in private practice in Ithaca, New York, and the author of dozens of scientific articles and more than twenty books including Toxic Psychiatry: Why Therapy, Empathy and Love Must Replace the Drugs, Electroshock and Biochemical Theories of the “New” Psychiatry, as well as his newest book, Medication Madness. The Empathic Therapy Conference brings together more than forty presenters and a diverse audience from around the world. Professionals and nonprofessionals are welcome. Learn about the conference at http://www.empathictherapy.org.

« Return to news items


Share

Psychiatrist Asks, “Why Are People So Divided When It Comes To Children’s Mental Health?” We’ve Got the Answer…

Tuesday, December 7th, 2010

20 million kids are being prescribed dangerous mind-altering drugs

By CCHR

Today’s Huffington Post features an article from psychiatrist Harold Koplewicz, frequently seen in the press leading the cheer for more psychiatric diagnosing and drugging of children.   In today’s article, Koplewicz makes a plea to ‘Stop the Stigma’ which is preventing children from being diagnosed mentally ill.   Pretty catchy slogan isn’t it? “Stop the Stigma.”  It ought to be, it’s a brilliant marketing campaign, brought to you by Big Pharma, via the National Alliance on Mental Illness (NAMI), a group that  masquerades as a “patient’s rights group for the mentally ill”  but receives tens of millions in Pharma funding.

But here’s the real rub—What entity is most responsible for stigmatizing millions of children? What group has pathologized childhood behavior and repackaged a list of behaviors into a “disease” called ADHD?  Psychiatry and Pharma.   You can’t be a kid anymore.  If you display child-like behaviors you can be  branded mentally ill for life. And its not just us saying this.  Consider that the former Chairman of the American Psychiatric Association’s DSM task force,  psychiatrist Allen Frances, stated “Our country is in the midst of a fifteen year ‘epidemic’ of Attention Deficit Disorder (ADD). There are six potential causes for the skyrocketing rates of ADD—but only five have been real contributors. The most obvious explanation is by far the least likely – that the prevalence of attention deficit problems in the general population has actually increased in the last 15 years. Human nature is remarkably constant and slow to change, while diagnostic fads come and go with great rapidity. We don’t have more attention deficit than ever before-we just label more attentional problems as mental disorder.”

He  also talked about “stigma,” but sourced the industry creating it—psychiatry: “The ‘epidemic’ of childhood Bipolar Disorder has created a public health dilemma” and that it is  “based on much hype and very little scientific evidence. The label Bipolar Disorder also carries considerable stigma, implying that the child will have a lifelong illness requiring lifetime treatment.”

Exactly.

The title of Dr. Koplewicz’s article is “Why Are People So Divided When It Comes to Children’s Mental Health?” so we’d like to answer that question, as it’s pretty simple —Some of us are for children’s rights and putting their best interests above all else, while others are for Psycho/Pharma and putting their best interests above all else.

That’s the short version.  Here is a bit more detailed answer;

Point 1) Millions of children have been stigmatized with bogus psychiatric “labels” that are based solely on opinion, and not one shred of medical evidence that there’s anything physically wrong with them.  No blood tests, brain scans, X-rays, MRIs or any proof whatsoever they are “mentally ill” and require drugs euphemistically being called “medicine.”    Unlike real medical diseases which are discovered in labs, psychiatric diagnoses are invented by psychiatrists in committee, by  the following “scientific” process;  Cluster a number of behaviors into a nice little package, give it a name and add “disorder” on the tail end of it,  then take a vote.  Majority wins.   That’s about it. And that’s why mental disorders can be here one day and gone the next, because of majority opinion — namely, psychiatry’s.   So while psychiatrists talk about the “amazing progress” they’ve made, and how “close” they’ve come to proving mental disorders are “real medical conditions,” we’d like to point out the obvious—they haven’t.   They couldn’t prove mental disorders were physical/medical conditions 50 years ago, and can’t prove it today despite billions in government funding.    No progress.  Whatsoever.   Zippo.  Nada.    So understandably, Dr. Koplewicz,, as people become more educated about this ludicrous subjective process of disorders made to order, they are concerned about the lack of real science to psychiatric “diagnoses” particularly where their children are concerned.

Point 2) The majority of psychiatrists within the American Psychiatric Association that “decide” on what will and will not be a mental “disorder” are funded by Pharma.  That’s called a Conflict of Interest.  A serious, egregious conflict of interest.  No “conspiracy” here Dr. Kopelwicz, just some facts about your colleagues and their incentives for developing more mental disorders.

Point 3) Due to these subjective, invented mental disorders,  20 million children are currently taking mind-altering, life-threatening drugs, acknowledged by international drug regulatory agencies to cause future drug dependence, stunted growth, mania, psychosis, violence, aggression, hallucinations, heart attack, stroke, sudden death and suicidal ideation.  All international studies and warnings on psychiatric drugs along with all the reports filed with the U.S. FDA’s Medwatch by doctors, pharmacists and healthcare providers reporting suicidal ideation and death from psychiatric drugs given to toddlers, young children and teenagers can be found here:  http://www.cchrint.org/psychdrugdangers/

Point 4) While Koplewicz has the audacity to call the “over-drugging” of children “a myth”,  consider that the Government Accountability Office has launched a federal investigation into the massive increase of drugging children in foster care.  “The investigators will attempt to account for estimates in the hundreds of millions of dollars of possible fraud arising from prescriptions for drugs explicitly barred from Medicaid coverage.  The GAO is collecting data from six states to search for patterns of abuse.  According to a number of foster care experts who spoke with Politics Daily, children in foster care, who are typically concurrently enrolled in Medicaid, are three or four more times as likely to be on psychotropic medications than other children on Medicaid. Alarmingly, many of these drugs are medically prohibited for minors and dangerous to the children taking them.”

Point 5) Senate investigations this past year revealed that some of the “leading” psychiatrists touting the wonders of diagnosing and drugging kids, and largely responsible for massive increases in kids unnecessarily placed on dangerous psychiatric drugs, were on Pharma’s payroll, and failed to disclose this.  Psychiatrists such as Joseph Biederman, who was being paid millions of dollars by the Pharmaceutical companies while skewing the results of drug trials to show false benefits for kids, in order the launch a nationwide campaign to get children diagnosed as “bi-polar.”

And he’s not the only one: Here are some of the “leading” psychiatrists exposed by Senate investigations:

Melissa DelBello, Associate Professor of Psychiatry and Pediatrics at the University of Cincinnati, was exposed in 2007 by the Senate Finance Committee for concealing $180,000 she received from AstraZeneca in 2003 and 2004.  DelBello’s studies of the antipsychotic Seroquel, made by AstraZeneca, in children helped to fuel the widespread pediatric use of antipsychotic drugs.

In 2008, Joseph Biederman, a leading Harvard child psychiatrist whose work helped fuel an explosion in the use of powerful antipsychotic drugs in children, was exposed for withholding earning at least $1.6 million in consulting fees from drug makers between 2000 and 2007.

Alan Schatzberg, president-elect of the APA, and Professor and Department of Psychiatry Chair of Stanford University was also investigated in 2008 by the Senate Finance Committee.  Schatzberg was forced to step down as principal investigator in an NIH funded research project into a drug called Mifeprestone, to treat “psychotic depression.” Senate investigators found that Schatzberg failed to report $4.8 million worth of stock in Corcept Therapeutics, a drug company which he co-founded and acted as lead researcher on a drug development project for until he was forced to surrender that role after being exposed.

A Senate investigation found Charles Nemeroff, Professor of Psychiatry and Behavioral Sciences and Chairman of Psychiatry and Behavioral Sciences, Emory University School of Medicine had concealed $2.8 million he earned from drug companies. He was forced to step down as Chairman of Psychiatry and Behavioral Sciences at Emory due to being exposed for his hidden pharmaceutical pay and attempted cover up.

In December 2009, Sen. Charles Grassley filed a complaint about Fernando Mendez-Villamil to federal authorities for his excessive prescribing of antipsychotics to children that were not approved by the FDA.  This cost taxpayers $43 million over six years.  Mendez-Villamil is apparently also currently under investigation by the Medicaid program.  Mid 2009, the Florida Agency for Health Care Administration reported that that Mendez Villamil is the top Medicaid prescriber of mental health drugs in the state—for all ages.  It was calculated that he wrote more than 150 prescriptions a day, seven days a week for six years

So to summarize, we don’t have an epidemic of mentally ill children, we have an epidemic of psychiatry stigmatizing children with mental disorders that cannot be medically/scientifically proven to exist.  We have an epidemic of children prescribed dangerous and potentially lethal psychiatric drugs, including infants and toddlers.  And we have the real source of stigmatization—the Psychiatric/Pharmaceutical industry.

To read Koplewicz’s article, click here

http://www.huffingtonpost.com/dr-harold-koplewicz/mental-health-being-openminded_b_791706.html

« Return to news items


Share

Another Psychiatric Drug, Another Potential Criminal Investigation—J&J’s Antipsychotic Risperdal

Thursday, November 11th, 2010

Wall Street Journal, November 10, 2010

by Peter Loftus of Dow Jones Newswires

Johnson & Johnson (JNJ) said it’s in discussions with the government to resolve a long-running investigation of whether it improperly marketed the antipsychotic Risperdal.

“Discussions are ongoing in an effort to resolve potential criminal and civil litigation arising from these matters,” J&J disclosed in a regulatory filing Wednesday. “Whether a resolution can be reached and on what terms is uncertain.”

J&J spokesman Jeff Leebaw declined further comment.

Risperdal, which is approved to treat schizophrenia and bipolar disorder, was once J&J’s best-selling drug, with global sales of about $4.9 billion in 2007, according to IMS Health, before its oral formulation lost patent protection and cleared the way for generic competition.

J&J has previously disclosed government inquiries regarding Risperdal and later, a newer antipsychotic, Invega, but hadn’t previously said it was in talks for a settlement.

In 2004, the Office of the Inspector General of the U.S. Office of Personnel Management issued a subpoena seeking documents regarding sales and marketing of Risperdal, as well as payments to physicians and clinical trials for the drug, from 1997 to 2002.

The U.S. Attorney’s Office in Philadelphia sent an additional subpoena in 2005, seeking information about Risperdal marketing and adverse reactions associated with the drug. Grand jury subpoenas have been issued seeking testimony from various witnesses.

Earlier this year, J&J, of New Brunswick, N.J., disclosed the government had served civil investigative demands seeking additional information about the marketing of Risperdal and Invega.

Other makers of popular antipsychotics have settled government probes of marketing practices in recent years. In April, AstraZeneca PLC (AZN) agreed to pay about $520 million to resolve Justice Department allegations that it promoted Seroquel off label, or for uses not approved by the Food and Drug Administration.

Last year, Eli Lilly & Co. (LLY) agreed to pay more than $1.4 billion and pleaded guilty to a criminal charge, admitting it promoted the antipsychotic Zyprexa for off-label uses including treatment of dementia in the elderly.

The drugs also have been linked to safety risks, including increased risk of death if used by elderly patients with dementia-related psychosis, as well as weight gain.

Several U.S. states have filed lawsuits against J&J seeking reimbursement of Medicaid funds used to pay for off-label uses of Risperdal, as well as compensation for treating beneficiaries for alleged adverse reactions to the drug.

In October, a jury in Louisiana awarded the state $257.7 million after concluding that J&J minimized the drug’s risk of causing weight gain leading to diabetes. J&J said it would appeal the verdict because the jury wasn’t properly told of applicable legal standards, and certain evidence was excluded. J&J said it didn’t violate the law.

Read the rest of the article here: http://online.wsj.com/article/BT-CO-20101110-717532.html

« Return to news items


Share

Hundreds of U.S. Pilots Treated for Drug Abuse and Psychiatric Disorders, Review Finds

Wednesday, September 15th, 2010

Note From CCHR: If the fact that commercial airline pilots are now allowed to fly while under the influence on antidepressants and antipsychotic drugs doesn’t send off any alarm bells, then perhaps you should take two minutes and try this— go to this link http://www.cchrint.org/psychdrugdangers/drug_warnings.php and in the Search box (with the red text) simply type in the word suicide and scroll down the page to quickly look over the results.   Then search  aggression,  hallucinations, violence and psychosis.   By reversing their previous ruling and now allowing commercial airline pilots to fly under the influence of these drugs, the FAA is playing a game of Russian Roulette with all of us.

FoxNews.com

Published September 15, 2010

By Jessica Heslam

Boston Herald

Hundreds of commercial and private U.S. pilots have been diagnosed and treated for a broad array of serious psychiatric and medical conditions, including schizophrenia, attempted suicide, sexual deviance, alcoholism and drug abuse, a Herald review has found.

The review comes in the wake of a chilling episode at Logan International Airport four months ago involving a distraught JetBlue [JBLU] pilot who threatened to “harm himself in spectacular fashion” an hour before takeoff – an incident that sent shudders through airline passengers across the country.

Medical record data from 2008, 2009 and 2010 provided by the Federal Aviation Administration under a public records request show:

– 15 pilots – including one from Massachusetts – have been treated for or diagnosed with schizophrenia.

– Another 292 pilots have attempted suicide, including five Bay Staters.

– 2,700 pilots have been treated for alcohol abuse, including 34 from Massachusetts, and another 1,253 have been diagnosed as alcoholics – including 20 Bay Staters.

– 1,377 pilots have been treated for drug abuse – 23 from Massachusetts – and another 94 for drug dependence.

Read the rest of this article here:  http://www.foxnews.com/us/2010/09/15/hundreds-pilots-treated-drug-abuse-psychiatric-disorders-review-finds/?test=latestnews

« Return to news items


Share

Overmedication contributes to military suicides, advocates say

Thursday, August 12th, 2010
By Veronica Nett
The Charleston Gazette

CHARLESTON, W.Va. — The suicide rate among military veterans has ballooned in recent years, in part because of overmedication of service members and a lack of support for veterans, advocates for treatment of Post Traumatic Stress Disorder said Thursday.

Psychiatrists sometimes prescribe drugs as a cure without an actual understanding of what the drugs do, said Dr. Peter R. Breggin, a psychiatrist and author from Ithaca, N.Y.

In 2008, the Army’s suicide rate — 20.2 per 100,000 — exceeded the civilian suicide rate for the first time. The civilian suicide rate has held steady for years at about 18 per 100,000, according to the U.S. Department of Defense.

Breggin and seven panelists addressed a crowd of about 50 therapists, social workers, members of the state Veterans Affairs department, in addition to service members and their families at the 2010 PTSD and Traumatic Brain Injury Education and Awareness Conference.

Care-Net, a branch of the state Council of Churches, sponsored the conference at the Blessed John XXIII Pastoral Center in Charleston.

PTSD is the brain’s natural reaction to extreme stress and traumatizing experiences, said Breggin, the conference’s keynote speaker. Tramuatic brain injury looks just like PTSD, he said.

“There is no drug that improves the function of the brain,” said Breggin, who said he will not prescribe psychiatric drugs as treatment for any disorder.

Psychiatric drugs, such as antidepressants and anxiety medication, alter the chemical balance in the brain, disrupt the release of serotonin and, in many cases, have the same effect as street drugs, Breggin said.

Patients using psychiatric drugs have experienced psychotic and violent behavior, attempted suicide and are unable to think clearly, Breggin said.

Mary Lahas talked about her son, Michael, who she said stuck IV needles into his arms in a suicide attempt.

Her son, an Army infantry member, survived roadside bomb explosions, and witnessed the shooting death of civilians in Iraq, Lahas said Thursday.

He returned from his first deployment in 2008 with PTSD and TBI and suffered from headaches, anxiety, guilt, tinnitus and memory problems, Lahas said. He refused to seek help, she said, because he saw other soldiers ridiculed who did.

When he finally did seek help, he was given a “cocktail of death,” that included antidepressants, anxiety medications and sleep aids, Lahas said.

“He was so overmedicated he could not care for himself — eat, sleep or brush his teeth,” she said.

The drugs and stress led him to try to take his own life, and while standing in his bathroom bleeding, he drew a smiley face on the wall in his own blood, she said.

Read the rest of this article here: http://wvgazette.com/News/201008120975

« Return to news items


Share

CBS Health News: Will New Psych “Bible” Make Everyone Crazy?

Thursday, July 29th, 2010

CBS News
By David W. Freeman
July 29, 2010

Is anyone normal anymore?

An updated edition of the medical reference doctors use to diagnose mental illnesses could include a range of brand-new disorders, including some that describe thought patterns and behaviors that have long been considered mere quirks or examples of eccentric behavior.

Like what?

Are you angry at something or do you have “temper dysregulation disorder?”

Feeling upset or do you have “mild anxiety depression?”

And then there’s “psychosis risk syndrome,” a diagnosis that could apply to people who seem merely to be at increased risk for full-blown psychosis,.

The new edition of the book – the “Diagnostic and Statistical Manual,” or “DSM” – is considered the bible of mental illness. It contains specific criteria for diagnosing mental illness and is used around the world.

The new edition of the DSM isn’t due out till 2013. But medical experts met on Tuesday to discuss changes being considered to the text, Reuters reports.

Will the revised DSM help people get treatment for psychological problems that now go undiagnosed and treated? Or will it understate the impact of mental illness by suggesting that the term applies to a much wider swath of the population?

Some doctors worry that with so many new disorders, few people will be classified as mentally healthy.

Read entire article here:  http://www.cbsnews.com/8301-504763_162-20012048-10391704.html

« Return to news items


Share